The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer’s disease, formed by the accumulation of tau protein into ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

If all this sounds familiar, you’re probably thinking of Theranos, but SiPhox says their product really works and could be in ...

Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the ...

A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...

Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...

The healthcare management platform secured another partnership to improve health outcomes for professional athletes.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

A cerebrospinal fluid biomarker test can detect early Alzheimer's pathology by identifying small amounts of clumping-prone tau protein and its misfolded forms, years before they appear on brain scans.